Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesOtorhinolaryngology (ENT)UnitedHealthcare Hearing Aid Update | OpenPayer
    Ask Trek AI about this page
    ModifiedUnitedHealthcarePolicy CS052IN.11

    Hearing Aids and Devices Including Wearable, Bone-Anchored, and Semi-Implantable (for Indiana Only)

    Customize your policy alerts

    Sign up for UnitedHealthcare Policy CS052IN.11 alerts

    Get alerted when Policy CS052IN.11 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and medical-necessity review for wearable air-conduction hearing aids, bone-anchored or bone-conduction hearing aids, and semi-implantable hearing aids and related devices for UnitedHealthcare Community Plan members in Indiana.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerUnitedHealthcare
    PolicyHearing Aids and Devices Including Wearable, Bone-Anchored, and Semi-Implantable (for Indiana Only)
    Policy CodePolicy CS052IN.11
    Change TypeModified
    Effective DateOctober 1, 2026
    Next Review DateN/A
    Key ActionApply the applicable Indiana Health Coverage Programs or InterQual clinical criteria based on the device and whether the criteria are state-specific.
    SourceLink
    POLICY UPDATE CHANGES

    Medical necessity criteria for semi-implantable hearing aids were revised to require sensorineural hearing loss, inability to use an air-conduction hearing aid, and use according to FDA labeling.

    The policy removed its reference to InterQual CP: Procedures, Hearing Device, Middle Ear.

    The description of services, clinical evidence, and references sections were updated to reflect current information.

    INApplicable state
    4Primary device categories
    5Unproven device types
    20+Wearable hearing-aid codes

    Medical Necessity and Coverage Criteria

    Wearable Air Conduction Hearing Aids — State-Specific Criteria

    For clinical coverage criteria, including repair and replacement criteria, refer to the Indiana Health Coverage Programs, Provider Reference Module: Hearing Services.

    Indiana-specific criteria: Apply the Indiana Health Coverage Programs, Provider Reference Module: Hearing Services clinical coverage criteria, including repair and replacement criteria.

    The applicable state-specific criteria are incorporated by reference.

    Wearable Air Conduction Hearing Aids — Non-State-Specific Criteria

    For medical-necessity clinical coverage criteria, refer to InterQual CP: Durable Medical Equipment, Hearing Aids.

    Referenced medical-necessity criteria: Apply the InterQual CP: Durable Medical Equipment, Hearing Aids medical-necessity criteria.

    The applicable non-state-specific criteria are incorporated by reference.

    Bone-Anchored or Bone-Conduction Hearing Aids

    For medical-necessity clinical coverage criteria, refer to the applicable InterQual procedures.

    Applicable InterQual procedure: Apply the applicable InterQual CP: Procedures criterion for Hearing Device, Bone Anchored or Bone Conduction, or Hearing Device, Bone Anchored or Bone Conduction (Pediatric), as applicable.

    Separate general and pediatric procedures are identified.

    Semi-Implantable Hearing Aids

    A semi-implantable electromagnetic hearing aid is proven and medically necessary when all of the following conditions are met.

    All required conditions

    • The individual has hearing loss.
    • The individual is not a candidate for an air-conduction hearing aid.
    • The device is used according to U.S. Food and Drug Administration-labeled indications, contraindications, warnings, and precautions.

    Bilateral or Unilateral Bone-Anchored Hearing Aids Without Osseointegration

    For medical-necessity clinical coverage criteria, refer to InterQual CP: Durable Medical Equipment, Hearing Aids.

    Referenced medical-necessity criteria: Apply the InterQual CP: Durable Medical Equipment, Hearing Aids medical-necessity criteria for bilateral or unilateral bone-anchored hearing aids utilizing a headband or adhesive without osseointegration.

    The policy does not reproduce the detailed InterQual criteria.

    Semi-Implantable Hearing Aid for Sensorineural Hearing Loss

    A semi-implantable electromagnetic hearing aid is considered proven and medically necessary when all of the following are met.

    All-of eligibility criteria

    • The individual has sensorineural hearing loss.
    • The individual is not a candidate for an air-conduction hearing aid.
    • The device is used according to U.S. Food and Drug Administration-labeled indications, contraindications, warnings, and precautions.

    Intraoral bone-conduction hearing aids, laser or light-based hearing aids, and totally implanted middle-ear hearing systems are considered unproven and not medically necessary for treating hearing loss because of insufficient evidence of efficacy.

    FDA approval or clearance alone is not a basis for coverage. Coverage remains subject to the applicable medical-necessity and benefit criteria.

    There are currently no FDA-approved intraoral bone-conduction hearing aids. The SoundBite Hearing System received FDA clearance in 2011, but Sonitus Medical filed for bankruptcy in 2015 and manufacturing of the device ceased.

    Intraoral bone-conduction hearing aids, laser or light-based hearing aids, and totally implanted middle-ear hearing systems are not medically necessary because they are considered unproven due to insufficient evidence of efficacy.

    Covered Codes and Clinical Coding Parameters

    Bone Anchored Hearing Aids (BAHA)CPT
    69710Implantation or replacement of electromagnetic bone conduction hearing device in temporal bone.
    69714Implantation, osseointegrated implant, skull; with percutaneous attachment to external speech processor.
    69716Implantation, osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor, within the mastoid and/or resulting in removal of less than 100 sq mm surface area of bone deep to the outer cranial cortex.
    69717Replacement, including removal of existing device, osseointegrated implant, skull; with percutaneous attachment to external speech processor.
    69799Unlisted procedure, middle ear.
    Semi-Implantable Electromagnetic Hearing Aids (SEHA)CPT
    0951TTotally implantable active middle ear hearing implant; initial placement, including mastoidectomy, placement of and attachment to sound processor.
    0952TTotally implantable active middle ear hearing implant; revision or replacement, with mastoidectomy and replacement of sound processor.
    0953TTotally implantable active middle ear hearing implant; revision or replacement, without mastoidectomy and replacement of sound processor.
    0954TTotally implantable active middle ear hearing implant; replacement of sound processor only, with attachment to existing transducers.
    0955TTotally implantable active middle ear hearing implant; removal, including removal of sound processor and all implant components.
    Bone Anchored Hearing Aids (BAHA)HCPCS
    L8690Auditory osseointegrated device, includes all internal and external components.
    L8693Auditory osseointegrated device abutment, any length, replacement only.
    L8694Auditory osseointegrated device, transducer/actuator, replacement only, each.
    Semi-Implantable Electromagnetic Hearing Aids (SEHA)HCPCS
    S2230Implantation of magnetic component of semi-implantable hearing device on ossicles in middle ear.
    V5095Semi-implantable middle ear hearing prosthesis.
    Wearable Hearing AidsHCPCS
    L8692Auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment.
    V5030Hearing aid, monaural, body worn, air conduction.
    V5040Hearing aid, monaural, body worn, bone conduction.
    V5050Hearing aid, monaural, in the ear.
    V5060Hearing aid, monaural, behind the ear.
    V5070Glasses, air conduction.
    V5080Glasses, bone conduction.
    V5100Hearing aid, bilateral, body worn.
    V5120Binaural, body.
    V5130Binaural, in the ear.
    1–10 of 43
    1/5
    Wearable Hearing AidsHCPCS
    L8692Auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment
    V5030Hearing aid, monaural, body worn, air conduction
    V5040Hearing aid, monaural, body worn, bone conduction
    V5050Hearing aid, monaural, in the ear
    V5060Hearing aid, monaural, behind the ear
    V5070Glasses, air conduction
    V5080Glasses, bone conduction
    V5100Hearing aid, bilateral, body worn
    V5120Binaural, body
    V5130Binaural, in the ear
    1–10 of 47
    1/5
    Degree of Hearing Loss
    Normal-10 to 15 dBHL
    Slight through moderately severeSlight: 16 to 25 dBHL; mild: 26 to 40 dBHL; moderate: 41 to 55 dBHL; moderately severe: 56 to 70 dBHL
    Severe and profoundSevere: 71 to 90 dBHL; profound: 91 dBHL or more
    Vibrant Soundbridge Air-Conduction Thresholds
    500 Hz30 to 65 dB
    1,000–2,000 Hz

    Provider Review and Documentation Requirements

    Documentation Required

    Medical-Necessity Documentation Required

    Ensure the patient's medical record fully supports the medical necessity of the requested services. Documentation must include relevant medical history, physical examination findings, and results of pertinent diagnostic tests or procedures; it must be legible, maintained in the medical record, and available upon request. Documentation does not guarantee coverage.

    • Relevant medical history
    • Physical examination findings
    • Results of pertinent diagnostic tests or procedures
    • Legible records maintained in the patient's medical record and available upon request
    Documentation Required

    Qualified Specialist and Regulatory-Use Documentation

    Document the qualified specialist's recommendation and confirm that device use follows applicable regulatory restrictions and guidelines. Recommendations for active middle-ear implants and bone-conduction devices should be made by a qualified otolaryngologist-head and neck surgeon, and use should comply with FDA or other applicable governing-agency requirements.

    Policy Background

    Hearing aids are sound-amplifying devices used to assist people with hearing impairment. For this policy, hearing aids include wearable devices, bone-anchored or bone-conduction hearing aids, semi-implantable electromagnetic hearing aids, and certain non-wearable hearing devices or systems. The policy addresses hearing loss that may be conductive, sensorineural, or mixed; conductive loss involves impaired sound transmission through the outer or middle ear, while sensorineural loss involves the cochlea or auditory nerve and is commonly permanent.

    Hearing and Device Definitions

    Conductive Hearing Loss
    Site of impaired conductionOuter ear canal, eardrum, or ossicles of the middle ear
    Typical effectReduction in sound level or ability to hear faint sounds
    CorrectabilityCan often be corrected medically or surgically
    Degree of Hearing Loss
    Normal hearing-10 to 15 dBHL
    Slight, mild, and moderate lossSlight: 16 to 25 dBHL; mild: 26 to 40 dBHL; moderate: 41 to 55 dBHL
    Moderately severe, severe, and profound loss
    Policy Summary
    PayerUnitedHealthcare
    PolicyHearing Aids and Devices Including Wearable, Bone-Anchored, and Semi-Implantable (for Indiana Only)
    Policy CodePolicy CS052IN.11
    Change TypeModified
    Effective DateOctober 1, 2026
    Next Review DateN/A
    Key ActionApply the applicable Indiana Health Coverage Programs or InterQual clinical criteria based on the device and whether the criteria are state-specific.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaCovered Codes and Clinical Coding ParametersProvider Review and Documentation RequirementsPolicy BackgroundHearing and Device Definitions
    1,000 Hz: 40 to 75 dB; 1,500 Hz: 45 to 80 dB; 2,000 Hz: 45 to 80 dB
    3,000–4,000 Hz3,000 Hz: 50 to 85 dB; 4,000 Hz: 50 to 85 dB
    Vibrant Soundbridge Word Recognition
    Minimum word recognition score50% or better using recorded material
    Assessment typeWord Recognition Score using recorded material
    Related selection contextUsed in the Vibrant Soundbridge selection criteria
    Bone-Anchored Device Thresholds
    General thresholdBone-conduction PTA generally better than or equal to 45 dB HL
    Applicable conditionsConductive or mixed hearing loss with ability to benefit from amplification
    Device dependenceThe specific threshold depends on the device and indication
    Baha and Related Device Thresholds
    Baha Attract with BP100Better than or equal to 45 dB HL
    Baha Attract with BP110055 dB HL
    Baha 7Better than or equal to 55 dB HL
    SoundArcAt least 45 dB HL with BP100, Baha 4, or Baha 5; 55 dB HL with BP110 Power or Baha 5 Power; at least 65 dB HL with Cordelle II or Baha 5 SuperPower
    BONEBRIDGE and Osia Thresholds
    BONEBRIDGEBetter than or equal to 45 dB HL at 0.5, 1, 2, and 3 kHz
    Osia SystemBetter than or equal to 55 dB HL at 0.5, 1, 2, and 3 kHz
    Osia 2 SystemBetter than or equal to 55 dB HL at 0.5, 1, 2, and 3 kHz
    Symmetric Bilateral Fitting
    Average interaural differenceLess than 10 dB
    Individual-frequency differenceLess than 15 dB
    ApplicationSymmetric bilateral fitting for conductive or mixed hearing loss
    Baha BP100 Threshold
    ThresholdBetter than or equal to 45 dB HL
    Frequencies0.5, 1, 2, and 3 kHz
    ProcessorBaha BP100
    Baha SoundArc Thresholds
    BP100, Baha 4, and Baha 5Better than or equal to 45 dB HL
    BP110 Power and Baha 5 Power55 dB HL
    Cordelle II and Baha 5 SuperPowerBetter than or equal to 65 dB HL
    Frequencies0.5, 1, 2, and 3 kHz
    Bilateral Bone-Conduction Symmetry
    Average difference between earsLess than 10 dB
    Individual-frequency differenceLess than 15 dB
    Measurement frequenciesGenerally 0.5, 1, 2, and 3 kHz; the Otomag description specifies 0.5, 1, 2, and 4 kHz for average measurement
    Normal Contralateral Hearing for SSD
    PTA air-conduction thresholdBetter than or equal to 20 dB HL
    Frequencies0.5, 1, 2, and 3 kHz
    ApplicationNormal hearing in the contralateral ear for SSD indications
    Otomag Threshold
    ThresholdBetter than 45 dB HL
    Frequencies0.5, 1, 2, and 3 kHz
    DeviceOtomag Alpha 1(S) Sound Processor or Otomag system
    ADHEAR Threshold
    Bone-conduction thresholdBetter than or equal to 25 dB HL
    Frequencies0.5, 1, 2, and 3 kHz
    ApplicationConductive hearing loss or SSD via bone conduction
    • Active middle-ear implants: qualified otolaryngologist-head and neck surgeon involvement
    • Bone-conduction devices: recommendation by a qualified otolaryngology-head and neck surgeon
    • Follow FDA restrictions, guidelines, and approved indications
    Denial Risk

    Unproven Hearing-Device Types

    The following hearing-device types are unproven and not medically necessary for treating hearing loss because of insufficient evidence of efficacy. Identify these device types in the request and advise that they may be denied.

    • Intraoral bone conduction hearing aids
    • Laser or light-based hearing aids
    • Totally implanted middle ear hearing systems
    Documentation Required

    Semi-Implantable Device Eligibility

    A semi-implantable electromagnetic hearing aid for sensorineural hearing loss is proven and medically necessary only when used according to FDA-labeled indications, contraindications, warnings, and precautions, and when the individual is not a candidate for an air-conduction hearing aid.

    • Confirm sensorineural hearing loss
    • Confirm the individual is not a candidate for an air-conduction hearing aid
    • Document compliance with FDA-labeled indications, contraindications, warnings, and precautions
    Documentation Required

    Use Applicable Clinical Criteria

    Apply the clinical criteria appropriate to the device and member's coverage context. For Indiana wearable air-conduction hearing aids, including repair and replacement, use the Indiana Health Coverage Programs Provider Reference Module: Hearing Services; also apply the referenced InterQual criteria where applicable.

    • Indiana Health Coverage Programs, Provider Reference Module: Hearing Services — wearable air-conduction hearing aids, including repair and replacement
    • InterQual CP: Durable Medical Equipment, Hearing Aids — wearable air-conduction hearing aids and bilateral or unilateral bone-anchored hearing aids using a headband or adhesive without osseointegration
    • InterQual CP: Procedures: Hearing Device, Bone Anchored or Bone Conduction
    • InterQual CP: Procedures: Hearing Device, Bone Anchored or Bone Conduction (Pediatric)
    Billing Rule

    V5267 Requires Manual Review

    For plans that cover hearing aids, code V5267 requires manual review before a coverage determination can be made. Determine what the item is, then apply the applicable coverage and clinical criteria.

    • V5267 — Hearing aid or assistive listening device/supplies/accessories, not otherwise specified
    • Manual review is required to identify the item before determining coverage
    Denial Risk

    FDA Status Does Not Establish Coverage

    FDA approval or clearance alone is not a basis for coverage. Make the coverage determination using the applicable benefit, contractual requirements, and clinical coverage criteria.

    • Do not treat FDA approval or clearance alone as establishing coverage
    Denial Risk

    Non-FDA-Approved Intraoral Device

    An intraoral bone-conduction hearing aid presents a denial risk because there are currently no FDA-approved intraoral bone-conduction hearing aids. The SoundBite Hearing System received FDA clearance in 2011, but manufacturing ceased after Sonitus Medical filed for bankruptcy in 2015.

    • No FDA-approved intraoral bone-conduction hearing aids currently exist
    • SoundBite Hearing System: FDA-cleared in 2011; manufacturing ceased in 2015
    Moderately severe: 56 to 70 dBHL; severe: 71 to 90 dBHL; profound: 91 dBHL or more
    Hearing Aids
    DefinitionSound-amplifying devices designed to aid people who have hearing impairment
    Amplification technologyMay use analog or digital amplification
    Policy classificationSemi-implantable electromagnetic hearing aids, bone-anchored hearing aids, and certain non-wearable hearing devices or systems are considered hearing aids for this policy
    Hearing Impairment
    DefinitionA reduction in the ability to perceive sound
    RangeMay range from slight impairment to complete deafness
    Clinical scopeDescribes reduced hearing ability across the severity spectrum
    Mixed Hearing Loss
    DefinitionConductive hearing loss occurring in combination with sensorineural hearing loss
    Outer or middle ear componentDamage or dysfunction may occur in the outer or middle ear
    Inner ear or nerve componentDamage or dysfunction may also occur in the inner ear (cochlea) or auditory nerve
    Sensorineural Hearing Loss
    CauseDamage to the inner ear (cochlea) or nerve pathways from the inner ear to the brain
    Typical permanenceMost of the time, it cannot be medically or surgically corrected
    Clinical descriptionThe most common type of permanent hearing loss
    Intraoral Bone-Conduction Hearing Aid
    Device typeNon-surgical intraoral bone-conduction hearing aid
    ComponentsBehind-the-ear processor and removable, custom-fit oral retainer-like device
    Sound transmissionTransmits sound through the teeth and skull bones to both cochleae, bypassing the outer and middle ear
    Laser or Light-Based Hearing Aid
    ProcessorBehind-the-ear sound processor
    Signal conversionConverts sound into infrared light pulses
    TransducerRemovable tympanic-membrane transducer converts the pulses into vibrations applied directly to the tympanic membrane
    Semi-Implantable Electromagnetic Hearing Aid
    External componentExternal sound processor receives and amplifies sound
    Implanted componentImplanted magnetic device in the middle ear
    MechanismElectromagnetic and static magnetic fields create ossicular vibrations that transmit sound to the inner ear
    Totally Implanted Middle-Ear Hearing System
    Implant locationImplanted behind the outer ear and in the middle ear
    ComponentsImplanted sound processor, sensor, and driver
    OperationThe driver converts electrical signals from the sound processor for transmission to the inner ear; the system does not use an external microphone or speaker
    Single-Sided Deafness (SSD)
    ConditionSingle-sided deafness or unilateral sensorineural hearing loss in one ear
    Other earThe opposite ear has normal hearing
    Normal-hearing criterionPTA air-conduction threshold equal to or better than 20 dB at 0.5, 1, 2, and 3 kHz
    PTA
    DefinitionPure-tone average threshold measured across specified frequencies
    Common frequencies0.5, 1, 2, and 3 kHz
    Use in this policyUsed in device indications and hearing-threshold criteria
    Air-Conduction CROS
    Device typeAir-conduction hearing aid
    FunctionRoutes sound from the impaired side to the hearing ear
    Clinical contextUsed as an alternative or comparator in selected SSD indications
    SSD
    DefinitionUnilateral sensorineural deafness in one ear
    Opposite earNormal hearing in the opposite ear
    Related optionAn air-conduction CROS hearing aid may be indicated, but some individuals cannot or will not use one
    PTA
    DefinitionPure-tone average hearing threshold measured at specified frequencies
    Common frequencies0.5, 1, 2, and 3 kHz
    Measurement typeAir-conduction or bone-conduction threshold, depending on the indication
    Air-Conduction CROS Hearing Aid
    Device typeHearing aid using air conduction
    Routing functionRoutes sound from the poorer ear to the better-hearing ear
    Transmission pathwaySound is routed through air conduction